Cargando…
Lessons learned: A look back at the performance of nine COVID-19 serologic assays and their proposed utility
BACKGROUND: Serologic assays for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been proposed to assist with the acute diagnosis of infection, support epidemiological studies, identify convalescent plasma donors, and evaluate vaccine response. METHODS: We report an evaluation...
Autores principales: | Tolan, Nicole V., DeSimone, Mia S, Fernandes, Maria D, Lewis, Joshua E., Simmons, Daimon P, Schur, Peter H, Brigl, Manfred, Tanasijevic, Milenko J, Desjardins, Michaël, Sherman, Amy C, Baden, Lindsey R, Snyder, Marion, Melanson, Stacy EF |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Canadian Society of Clinical Chemists. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985916/ https://www.ncbi.nlm.nih.gov/pubmed/36878344 http://dx.doi.org/10.1016/j.clinbiochem.2023.03.003 |
Ejemplares similares
-
The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients
por: Tolan, Nicole V., et al.
Publicado: (2022) -
Estimated GFR With Cystatin C and Creatinine in Clinical Practice: A Retrospective Cohort Study
por: Gottlieb, Eric Raphael, et al.
Publicado: (2023) -
Perspectives on Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 and Its Implications for Diagnostics, Biology, and Clinical Management
por: Simmons, Daimon P., et al.
Publicado: (2022) -
Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19
por: Simmons, Daimon P., et al.
Publicado: (2022) -
Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2
por: Nilles, Eric J., et al.
Publicado: (2020)